Perchenet相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studies

PULSAR 和 STELLAR 研究的汇总分析显示，激活素信号抑制剂 sotatercept 具有疗效和安全性。

期刊:European Respiratory Journal

影响因子:21

doi:10.1183/13993003.01424-2024

Hoeper, Marius M; Gomberg-Maitland, Mardi; Badesch, David B; Gibbs, J Simon R; Grünig, Ekkehard; Kopeć, Grzegorz; McLaughlin, Vallerie V; Meyer, Gisela; Olsson, Karen M; Preston, Ioana R; Rosenkranz, Stephan; Souza, Rogerio; Waxman, Aaron B; Perchenet, Loïc; Strait, James; Xing, Aiwen; Manimaran, Solaiappan; Wang, Xuelong; Miller, Barry; Cornell, Alexandra G; de Oliveira Pena, Janethe; Ghofrani, H Ardeschir; Humbert, Marc

发表日期：2025

文献求助收藏

The diagnostic journey of pulmonary arterial hypertension patients: results from a multinational real-world survey

肺动脉高压患者的诊断历程：一项多国真实世界调查的结果

期刊:Therapeutic Advances in Respiratory Disease

doi:10.1177/17534666231218886

Small, Mark; Perchenet, Loïc; Bennett, Alex; Linder, Jörg

肺动脉高压

发表日期：2024

文献求助收藏

Time to diagnosis of pulmonary hypertension and diagnostic burden: A retrospective analysis of nationwide US healthcare data

肺动脉高压的诊断时间和诊断负担：一项基于美国全国医疗保健数据的回顾性分析

期刊:Pulmonary Circulation

影响因子:2.5

doi:10.1002/pul2.12188

Didden, Eva-Maria; Lee, Eileen; Wyckmans, Julie; Quinn, Deborah; Perchenet, Loïc

肺动脉高压

发表日期：2023

文献求助收藏

Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension

肺动脉高压的初始联合治疗方案为马西替坦和他达拉非。

期刊:European Respiratory Journal

影响因子:21

doi:10.1183/13993003.00673-2020

Sitbon, Olivier; Cottin, Vincent; Canuet, Matthieu; Clerson, Pierre; Gressin, Virginie; Perchenet, Loïc; Bertoletti, Laurent; Bouvaist, Hélène; Picard, François; Prévot, Grégoire; Bergot, Emmanuel; Simonneau, Gérald

肺动脉高压

发表日期：2020

文献求助收藏

Psychometric validation of the Hand Disability in Systemic Sclerosis-Digital Ulcers (HDISS-DU®) patient-reported outcome instrument

系统性硬化症-指端溃疡手部功能障碍（HDISS-DU®）患者自述结局指标的心理测量学验证

期刊:Arthritis Research & Therapy

影响因子:4.6

doi:10.1186/s13075-019-2087-4

Mouthon, Luc; Poiraudeau, Serge; Vernon, Margaret; Papadakis, Kelly; Perchenet, Loïc; Khanna, Dinesh

系统性硬化症

免疫/内分泌

发表日期：2020

文献求助收藏

Integrating Data From Randomized Controlled Trials and Observational Studies to Assess Survival in Rare Diseases

整合随机对照试验和观察性研究的数据以评估罕见病患者的生存率

期刊:Circulation-Cardiovascular Quality and Outcomes

影响因子:6.7

doi:10.1161/CIRCOUTCOMES.118.005095

Torbicki, Adam; Bacchi, Marisa; Delcroix, Marion; Farber, Harrison W; Ghofrani, Hossein-Ardeschir; Hennessy, Brian; Jansa, Pavel; Mehta, Sanjay; Perchenet, Loïc; Pulido, Tomas; Rosenberg, Daniel; Rubin, Lewis J; Sastry, B K S; Simonneau, Gérald; Sitbon, Olivier; Souza, Rogério; Wei, Lee-Jen; Channick, Richard; Benza, Raymond

发表日期：2019

文献求助收藏

Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial

六分钟步行距离与肺动脉高压患者长期预后之间的关联：来自随机SERAPHIN试验的数据

期刊:PLoS One

影响因子:2.6

doi:10.1371/journal.pone.0193226

Souza, Rogério; Channick, Richard N; Delcroix, Marion; Galiè, Nazzareno; Ghofrani, Hossein-Ardeschir; Jansa, Pavel; Le Brun, Franck-Olivier; Mehta, Sanjay; Perchenet, Loïc; Pulido, Tomás; Sastry, B K S; Sitbon, Olivier; Torbicki, Adam; Rubin, Lewis J; Simonneau, Gérald

肺动脉高压

发表日期：2018

文献求助收藏

SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension

SERAPHIN 血流动力学亚组研究：双重内皮素受体拮抗剂马西替坦对肺动脉高压患者血流动力学参数和 NT-proBNP 水平的影响及其与疾病进展的关系

期刊:European Heart Journal

影响因子:35.6

doi:10.1093/eurheartj/ehx025

Galiè, Nazzareno; Jansa, Pavel; Pulido, Tomás; Channick, Richard N; Delcroix, Marion; Ghofrani, Hossein-Ardeschir; Le Brun, Franck-Olivier; Mehta, Sanjay; Perchenet, Loïc; Rubin, Lewis J; Sastry, B K S; Simonneau, Gérald; Sitbon, Olivier; Souza, Rogério; Torbicki, Adam

肺动脉高压

发表日期：2017

文献求助收藏

Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN

肺动脉高压新发病例和患病人群：来自SERAPHIN研究的启示

期刊:European Respiratory Journal

影响因子:21

doi:10.1183/13993003.00364-2015

Simonneau, Gérald; Channick, Richard N; Delcroix, Marion; Galiè, Nazzareno; Ghofrani, Hossein-Ardeschir; Jansa, Pavel; Le Brun, Franck-Olivier; Mehta, Sanjay; Perchenet, Loic; Pulido, Tomás; Sastry, B K S; Sitbon, Olivier; Souza, Rogério; Torbicki, Adam; Rubin, Lewis J

肺动脉高压

发表日期：2015

文献求助收藏